Publications

5674 Results

Video productions in SELECT: effective tools for staff learning and participant motivation in clinical trials

Authors
JM Harris-Talley;D Arney;K Anderson;JA Hartline
Journal / Conference
Society for Clinical Trials 2010 Meeting; poster
Year
2010
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Should unknown primary melanomas be excluded from adjuvant therapy trials? Insights from the SWOG S0008 phase III randomized adjuvant trial

Authors
V Sondak;R Tuthill;J Moon;JA Thompson;C Lao;B Redman;LE Flaherty
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 8517) ASCO 2010 Meeting; poster
Year
2010
Research Committee(s)
Melanoma
Study Number(s)
S0008

Evaluation of minimal residual disease (MRD) in peripheral blood (PB) assessed prospectively by RT-PCR for melanoma-associated genes is an independent prognostic factor for survival in stage III melanoma (mel) patients (pts) enrolled onto an intergroup adjuvant trial S0008

Authors
J Sosman;J Moon;PY Liu;L Flaherty;MB Atkins;K Margolin;J Kirkwood;V Sondak
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 8513); ASCO 2010 Meeting; poster
Year
2010
Research Committee(s)
Melanoma
Study Number(s)
S0008

Paclitaxel-gemcitabine (P-G) for patients (pts) with advanced (adv) urothelial cancer (UC), aged > 70 years 9yrs): SWOG 0028

Authors
D Raghavan;C Tangen;C Moinpour;C Gotay;K Albain;S Louie;HJ Lenz;DI Quinn;MHA Hussain;IM Thompson
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 4569); ASCO 2010 Meeting; poster
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S0028

A phase II trial of biweekly gemcitabine and paclitaxel (GEMTAX) with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group study

Authors
KE Bickel;J Moon;O Kucuk;RH Wheeler;S Urba;G Wolf;FP Worden
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 5555); ASCO 2010 Meeting; poster
Year
2010
Research Committee(s)
Head and Neck
Study Number(s)
S0329

Circulating tumor cell capture and analysis in a multi-center SWOG-coordinated prostate cancer trial

Authors
A Goldkorn;T Xu;B Lu;A Williams;LM Fink;C Tangen;YC Tai;DI Quinn;P Twardowski;RJ Cote
Journal / Conference
Journal of Clinical Oncology 28:7s, 2010 (suppl;abstr TPS342); ASCO; poster
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S0421

Randomized phase II trial of sorafenib (SO) with temsirolimus (TEM) or tipifarnib (TIPI) in metastatic melanoma: Southwest Oncology Group trial S0438

Authors
K Margolin;J Moon;L Flaherty;C Lao;W Akerley;J Sosman;J Kirkwood;V Sondak
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 8502); ASCO 2010 Meeting; oral
Year
2010
Research Committee(s)
Melanoma
Study Number(s)
S0438

A randomized phase II trial of combination gemcitabine + erlotinib + IMC-A12 (cixutumumab) vs. gemcitabine + erlotinib as first-line treatment in patients (pts) with metastatic pancreatic cancer: Southwest Oncology Group Study (SWOG S0727)

Authors
PA Philip;B Goldman;RK Ramanathan;HJ Lenz;AM Lowy;RP Whitehead;S Iqbal;V Chung;J Benedetti;CD Blanke
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr TPS223); poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0727

Potential tumor biologic causes of the racial survival disparity in ER-positive breast cancer adjuvant trials

Authors
S Albain;W Barlow;S Shak;G Hortobagyi;D Hayes
Journal / Conference
Journal of Clinical Oncology 28:72s(suppl; abstr 511); oral
Year
2010
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Southwest Oncology Group (SWOG) trial S9917: Randomized phase 3 trial of selenium supplementation to prevent prostate cancer among men with high grade prostatic intraepithelial neoplasia (HGPIN)

Authors
J Marshall;C Tangen;W Sakr;DP Wood;S Lippman;D Jarrad;DS Alberts;DL Berry;ED Crawford;IM Thompson
Journal / Conference
American Urological Association Annual Meeting; late breaking, oral
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S9917